As President and Secretary of the European Society of Hypertension (ESH) and on behalf of the Scientific Council of the ESH, we would like to send this message to you during this difficult time of the COVID-19 pandemic.

This very difficult and challenging time has not only raised profound questions about many aspects of our social life, but has also brought many challenges in the field of medicine that go beyond the limits of management and care of COVID-19 patients.

Statement of the European Society of Hypertension (ESH) on hypertension, Renin Angiotensin System blockers and COVID-19.

The ESH task force on COVID-19 is in contact with experts and clinicians involved in care of COVID-19 patients and is continuously evaluating new information. Currently, we confirm our previous recommendations from last week, March 12th, 2020.

IMPORTANT NEWS!

In view of the unprecedented global situation related to COVID-19, we inform you that the ESH-ISH Joint Meeting in Glasgow, has been rescheduled to

April 11-14, 2021.

ESH-ISH 2021 is your meeting!

The STRIDE BP is an international scientific non-profit organization founded by hypertension experts with the mission to improve the accuracy of blood pressure measurement and hypertension diagnosis globally.

It is officially supported by the European Society of Hypertension, the International Society of Hypertension, and the World Hypertension League.